Rep. J. French Hill Sells Off CVS Health Co. (NYSE:CVS) Stock

Representative J. French Hill (R-Arkansas) recently sold shares of CVS Health Co. (NYSE:CVS). In a filing disclosed on February 04th, the Representative disclosed that they had sold between $15,001 and $50,000 in CVS Health stock on January 31st. The trade occurred in the Representative’s “HILL FAMILY FUND” account.

CVS Health Stock Performance

Shares of CVS stock opened at $55.62 on Thursday. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The firm has a 50-day moving average of $51.11 and a 200-day moving average of $56.06. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market cap of $69.99 billion, a P/E ratio of 14.12, a P/E/G ratio of 0.62 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the previous year, the business earned $2.21 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.78%. CVS Health’s payout ratio is currently 67.51%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the third quarter worth approximately $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health in the 4th quarter valued at $28,000. Livelsberger Financial Advisory purchased a new position in CVS Health in the 3rd quarter worth about $31,000. Finally, Legacy Investment Solutions LLC purchased a new stake in CVS Health during the third quarter valued at about $31,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of several recent analyst reports. Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Mizuho cut their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Finally, Royal Bank of Canada dropped their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $68.12.

About Representative Hill

French Hill (Republican Party) is a member of the U.S. House, representing Arkansas’ 2nd Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Hill (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 2nd Congressional District. He declared candidacy for the 2026 election.

Hill is the founder and chairman of Delta Trust & Bank. He has served as senior policy advisor to President George H.W. Bush, Deputy Assistant Secretary of the U.S. Treasury and senior advisor to Governor Mike Huckabee.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.